Shinohara Katsuto, Gulati Mittul, Koppie Theresa M, Terris Martha K
Department of Urology, University of California-San Francisco and UCSF/Mt. Zion Comprehensive Cancer Center, San Francisco, CA, USA.
J Urol. 2003 Jan;169(1):141-4. doi: 10.1016/S0022-5347(05)64054-2.
Prostate cancer evaluation in men who have undergone abdominoperineal resection poses a challenge for urologists. Diagnosis and staging methods are limited because as access to the prostate via digital rectal examination is not possible. Prostate specific antigen (PSA) has been used to screen for malignancy in this population. However, the conventional diagnostic technique with transrectal ultrasound guided biopsies cannot be used. Transperineal ultrasound and biopsy have been described to evaluate the prostate in this setting. We report our experience with transperineal ultrasound biopsy for evaluating the prostate in patients with elevated PSA who have previously undergone abdominoperineal resection.
We reviewed the records of 28 patients treated at 2 institutions. All patients had a history of abdominoperineal resection and subsequent transperineal ultrasound guided prostate biopsy for evaluating elevated PSA. Mean serum PSA in this population was 22 ng./ml. (median 9.5, range 4.1 to 237). Abdominoperineal resection was done in 16 patients (57%) for colorectal cancer, in 11 (39%) for ulcerative colitis and in 1 (4%) for familial polyposis coli. Average time since resection was 14 years (range 1 to 33). Five patients had previously undergone radiation therapy as part of treatment for colorectal cancer before transperineal ultrasound biopsy.
Of the 28 biopsies performed 23 revealed prostate cancer, 2 revealed prostatitis and 3 were benign. Average Gleason grade was 6.6 (range 3 to 9). Of the 23 patients with prostate cancer 22 were treated with androgen deprivation therapy (7), prostatectomy (8), external beam (6) and high dose (1) radiation therapy. Of the 8 patients who underwent prostatectomy pathological stage was T2 in 3 and T3 in 4, while pathological findings were not determined in 1 patient in whom the prostate was removed in pieces.
In patients with a history of abdominoperineal resection and elevated PSA transperineal ultrasound guided biopsy of the prostate can provide an accurate tissue diagnosis.
对于接受过腹会阴联合切除术的男性患者,前列腺癌评估对泌尿外科医生而言是一项挑战。由于无法通过直肠指检触及前列腺,诊断和分期方法受到限制。前列腺特异性抗原(PSA)已用于该人群的恶性肿瘤筛查。然而,无法使用经直肠超声引导活检这种传统诊断技术。经会阴超声及活检已被用于在此情况下评估前列腺。我们报告了经会阴超声活检在评估既往接受过腹会阴联合切除术且PSA升高患者前列腺方面的经验。
我们回顾了在两家机构接受治疗的28例患者的记录。所有患者均有腹会阴联合切除术病史,并随后接受经会阴超声引导下前列腺活检以评估PSA升高情况。该人群的平均血清PSA为22 ng/ml(中位数9.5,范围4.1至237)。16例患者(57%)因结直肠癌接受腹会阴联合切除术,11例(39%)因溃疡性结肠炎,1例(4%)因家族性腺瘤性息肉病。自切除术后的平均时间为14年(范围1至33年)。5例患者在经会阴超声活检前曾接受放射治疗作为结直肠癌治疗的一部分。
在进行的28次活检中,23次显示为前列腺癌,2次显示为前列腺炎,3次为良性。平均Gleason分级为6.6(范围3至9)。在23例前列腺癌患者中,22例接受了雄激素剥夺治疗(7例)、前列腺切除术(8例)、外照射(6例)和高剂量(1例)放射治疗。在接受前列腺切除术的8例患者中,病理分期3例为T2,4例为T3,1例患者前列腺被分块切除,病理结果未确定。
对于有腹会阴联合切除术病史且PSA升高的患者,经会阴超声引导下前列腺活检可提供准确的组织诊断。